Form 4 for BKYI BIO KEY INTERNATIONAL INC
Accepted 2023-11-01 00:00:00 ET · period of report 2023-10-30 · accession 0001437749-23-029811 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2023-11-01 | 2023-10-30 | BKYI | Sullivan James David | CLO, SVP Strategy, Compliance | P - Purchase | $0.18 | +57.1K | 415.6K | +16% | +$10.3K |
| D | 2023-11-01 | 2023-10-30 | BKYI | Sullivan James David | CLO, SVP Strategy, Compliance | P - Purchase | $0.18 | +228.0K | 358.5K | +175% | +$41.0K |
| D | 2023-11-01 | 2023-10-30 | BKYI | Sullivan James David | CLO, SVP Strategy, Compliance | P - Purchase | — | +228.0K | 246.8K | +1,216% | — |
| DI | 2023-11-01 | 2023-10-30 | BKYI | Sullivan James David | CLO, SVP Strategy, Compliance | P - Purchase | — | +57.1K | 303.9K | +23% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-30 | P | A | 57,100 | $0.18 | 415,600 | I | — | — | (F1) Holdings do not include options to purchase 18,750 shares and warrants to purchase 285,100 shares. |
| 2 | Common | Common Stock | 2023-10-30 | P | A | 228,000 | $0.18 | 358,500 | D Spouse | — | — | (F1) Holdings do not include options to purchase 18,750 shares and warrants to purchase 285,100 shares. |
| 3 | Derivative | Warrant | 2023-10-30 | P | A | 228,000 | — | 246,750 | D Spouse | $0.18 · 2023-10-31 to 2028-10-30 | 228,000 common stock | (F2) Warrants were purchased as part of a unit with each unit consisting of one share of common stock and one warrant at a purchase price of $0.175 per unit. |
| 4 | Derivative | Warrant | 2023-10-30 | P | A | 57,100 | — | 303,850 | I | $0.18 · 2023-10-31 to 2028-10-30 | 57,100 common stock | (F2) Warrants were purchased as part of a unit with each unit consisting of one share of common stock and one warrant at a purchase price of $0.175 per unit. |